Cargando…
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC) are the most frequent cancers in humans, with cumulative ultraviolet radiation exposure, aging, and immunodepression as the main risk factors. In most cases, these malignancies arise in the head and neck area, and they can be tr...
Autores principales: | Colombo, Elena, Gurizzan, Cristina, Ottini, Arianna, Caspani, Francesca, Bergamini, Cristiana, Locati, Laura D., Marchiselli, Chiara, Alberti, Andrea, Lorini, Luigi, Licitra, Lisa F., Bossi, Paolo, Resteghini, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013465/ https://www.ncbi.nlm.nih.gov/pubmed/36925925 http://dx.doi.org/10.3389/fonc.2023.1111146 |
Ejemplares similares
-
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021) -
Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature
por: Proietti, Ilaria, et al.
Publicado: (2023) -
Sonidegib for the Treatment of Advanced Basal Cell Carcinoma
por: Brancaccio, Gabriella, et al.
Publicado: (2020) -
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
por: Cavalieri, Stefano, et al.
Publicado: (2023) -
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?
por: Resteghini, Carlo, et al.
Publicado: (2017)